Michail Ignatiadis
Michail Ignatiadis
Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles
Geverifieerd e-mailadres voor bordet.be
Geciteerd door
Geciteerd door
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ...
Breast Cancer Research 10 (4), R65, 2008
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...
The Lancet Oncology 15 (4), 406-414, 2014
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751, 2015
CD4+ follicular helper T cell infiltration predicts breast cancer survival
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer
N Xenidis, M Ignatiadis, S Apostolaki, M Perraki, K Kalbakis, S Agelaki, ...
Journal of Clinical Oncology 27 (13), 2177-2184, 2009
Different prognostic value of cytokeratin-19 mrna–positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
M Ignatiadis, N Xenidis, M Perraki, S Apostolaki, E Politaki, M Kafousi, ...
Journal of clinical oncology 25 (33), 5194-5202, 2007
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling
HA Azim, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ...
Clinical cancer research 18 (5), 1341-1351, 2012
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
KS Saini, S Loi, E de Azambuja, O Metzger-Filho, ML Saini, M Ignatiadis, ...
Cancer treatment reviews 39 (8), 935-946, 2013
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early …
M Ignatiadis, G Kallergi, M Ntoulia, M Perraki, S Apostolaki, M Kafousi, ...
Clinical Cancer Research 14 (9), 2593-2600, 2008
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
FC Bidard, T Fehm, M Ignatiadis, JB Smerage, C Alix-Panabières, ...
Cancer and Metastasis Reviews 32 (1-2), 179-188, 2013
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ...
PloS one 6 (6), 2011
Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility
M Ignatiadis, M Lee, SS Jeffrey
Clinical Cancer Research 21 (21), 4786-4800, 2015
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
DJ McBride, AK Orpana, C Sotiriou, H Joensuu, PJ Stephens, LJ Mudie, ...
Genes, Chromosomes and Cancer 49 (11), 1062-1069, 2010
Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis
M Ignatiadis, SK Singhal, C Desmedt, B Haibe-Kains, C Criscitiello, ...
J Clin Oncol 30 (16), 1996-2004, 2012
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F Rothé, JF Laes, D Lambrechts, D Smeets, D Vincent, M Maetens, ...
Annals of oncology 25 (10), 1959-1965, 2014
HER2-positive circulating tumor cells in breast cancer
M Ignatiadis, F Rothe, C Chaboteaux, V Durbecq, G Rouas, C Criscitiello, ...
PloS one 6 (1), 2011
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
M Ignatiadis, SJ Dawson
Annals of oncology 25 (12), 2304-2313, 2014
Luminal breast cancer: from biology to treatment
M Ignatiadis, C Sotiriou
Nature reviews Clinical oncology 10 (9), 494, 2013
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
DJE Peeters, B De Laere, GG Van den Eynden, SJ Van Laere, F Rothé, ...
British journal of cancer 108 (6), 1358-1367, 2013
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20